Laura L. Holman, MD
Fellow in Training
The University of Texas MD Anderson Cancer Center
PO Box 301439
Houston,
TX
USA
77230
Biographical Sketch: I'm currently a gynecologic oncology fellow and presented the baseline results of this survey at the 2012 SGO Annual Meeting. Furthermore my co-authors are recognized experts in the field of ovarian cancer screening.
Papers:
9 - Focused Plenary
Omentin: a potential tumor suppressor in the microenvironment associated with visceral obesity
129 - Featured Poster
Assessment of palliative care training in gynecologic oncology: a Gynecologic Oncology Fellows Research Network study
186 - Poster Session A
Gynecologic oncology fellow perspectives on research and career development symposia: a Gynecologic Oncology Fellows' and Allied Health Professionals' Research Network (GOFRN) survey study
293 - Poster Session A
Serum omentin concentration is a potential biomarker for complex atypical hyperplasia and endometrioid endometrial cancer
528 - Poster Session B
BRCA mutation status is not associated with diminished ovarian reserve among women at high risk for ovarian cancer